BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6879005)

  • 21. Surveillance after measles vaccination in children.
    Miller CL
    Practitioner; 1982 Mar; 226(1365):535-7. PubMed ID: 7088847
    [No Abstract]   [Full Text] [Related]  

  • 22. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles vaccine in the People's Republic of China.
    Xiang JZ; Chen ZH
    Rev Infect Dis; 1983; 5(3):506-10. PubMed ID: 6879006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
    Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
    Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants.
    Berry S; Hernandez H; Kanashiro R; Campos M; Azabache V; Gomez G; Gutierrez M; Weirs B; De Quadros C; Halsey N
    Pediatr Infect Dis J; 1992 Oct; 11(10):822-7. PubMed ID: 1408479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan.
    Ozaki T; Matsui Y; Kajita Y; Nishimura N
    Vaccine; 2002 Jun; 20(19-20):2618-22. PubMed ID: 12057621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse effects of single-component measles vaccine in school children.
    Tosun S; Olut AI; Tansug N
    Vaccine; 2017 Dec; 35(52):7309-7311. PubMed ID: 29128384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles vaccine: a 27-year follow-up.
    Ramsay ME; Moffatt D; O'Connor M
    Epidemiol Infect; 1994 Apr; 112(2):409-12. PubMed ID: 8150015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indices of humoral antimeasles postvaccinal immunity].
    Tikhonova NT; Prokudina IuA; Khrometskaia TM; Potemkina EE
    Vopr Virusol; 1975; (3):287-92. PubMed ID: 1162947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
    Ajjan N; Fayet MT; Biron G; Charbonnier C; Nicolas A; Triau R; Roumiantzeff M
    Dev Biol Stand; 1978; 41():209-16. PubMed ID: 111980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of measles vaccines after controlling for exposure.
    Garenne M; Leroy O; Beau JP; Sene I
    Am J Epidemiol; 1993 Aug; 138(3):182-95. PubMed ID: 8356961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants.
    Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY
    Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of measles and rubella through use of attenuated vaccines.
    Meyer HM; Hopps HE; Parkman PD; Ennis FA
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):128-35. PubMed ID: 685885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled epidemiological study of live measles vaccines in Poland.
    Polish Measles Vaccination Committee
    Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Urabe Am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children.
    Vesikari T; André FE; Simoen E; Florent G; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Acta Paediatr Scand; 1983 Jan; 72(1):41-6. PubMed ID: 6344551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of four live measles vaccines in Israel.
    Swartz T; Klingberg W; Nishmi M; Goldblum N; Gerichter C; Yofe Y; Cockburn WC
    Bull World Health Organ; 1968; 39(2):285-92. PubMed ID: 5303410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.